Table: Peptidream -2017/18 parent results
Aug 9 (Reuters)-
Peptidream Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Jun 30, 2018 Jun 30, 2017 Jun 30, 2019 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 6.43 4.90
(+31.3 pct) (+13.1 pct)
Operating 2.91 2.49
(+16.9 pct) (-2.3 pct)
Recurring 3.15 2.62
(+20.2 pct) (+10.6 pct)
Net 2.34 1.89
(+23.5 pct) (+19.6 pct)
EPS 19.35 yen 16.54 yen
EPS Diluted 17.79 yen 14.56 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Peptidream Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner